OR WAIT 15 SECS
Compared to placebo, cocoa and soy supplementation improved insulin and cholesterol markers in type 2 diabetic women.
U.K. researchers assigned 93 postmenopausal women with type 2 diabetes to a daily combination of two highly standardized ingredients: SoyLife from Frutarom Ltd. (Haifa, Israel) featuring 100 mg of soy isoflavones and Acticoa from Barry Callebaut (Zurich, Switzerland) featuring 850 mg of flavan-3-ols.
Compared to placebo, the cocoa and soy supplementation improved insulin resistance, decreased insulin levels, improved ratios of total cholesterol to HDL cholesterol, and reduced LDL cholesterol levels in subjects.
Both Frutarom and Barry Callebaut supported the study, now published in the journal Diabetes Care.